Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|25|3|584-e36

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.25, Iss.3, 2018-03, pp. : 584-e36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing–remitting multiple sclerosis: a systematic review and mixed treatment comparison

By Hutchinson Michael   Fox Robert J.   Havrdova Eva   Kurukulasuriya Nuwan C.   Sarda Sujata P.   Agarwal Sonalee   Siddiqui Mohd Kashif   Taneja Ankush   Deniz Baris  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 613-627

Informa Healthcare

Access to resources Recommend Favorite

Dimethyl fumarate treatment alters NK cell function in multiple sclerosis

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 2, 2018-02 ,pp. : 380-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

The neuronal component of gray matter damage in multiple sclerosis: A [11C]flumazenil positron emission tomography study

By  

ANNALS OF NEUROLOGY, Vol. 364-5134, Iss. 4, 2015-10 ,pp. : 554-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

The neuronal component of gray matter damage in multiple sclerosis: A [11C]flumazenil positron emission tomography study

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 4, 2015-10 ,pp. : 554-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

Teriflunomide for relapsing remitting multiple sclerosis

By  

PRESCRIBER, Vol. 26, Iss. 18, 2015-09 ,pp. : 11-14

John Wiley & Sons Inc

Access to resources Recommend Favorite